3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
10
Recruiting
7
Unknown
2
Terminated
1
Suspended
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Neoplasms
13
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
5
Prostatic Neoplasms
4
Neoplasm Metastasis
3
Melanoma
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Pancreatic Neoplasms
2
Neoplastic Cells, Circulating
2
Multiple Myeloma
2
Lung Neoplasms
2
Liver Neoplasms
2
Glioblastoma
2
Fibrosis
2
Colorectal Neoplasms
2
Cachexia
2
Vascular Malformations
1
Uterine Cervical Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Renal Insufficiency, Chronic
1
Recurrence
1
Pneumonia
1
Ovarian Neoplasms
1
Ovarian Cysts
1
Osteosarcoma
1
Obesity
1
Interventions
Cisplatin
18
pembrolizumab
12
Paclitaxel
9
Carboplatin
9
Radiotherapy
5
Gemcitabine
4
Fluorodeoxyglucose F18
4
Colposcopy
4
Brachytherapy
4
fludarabine
3
durvalumab
3
Surveys and Questionnaires
3
Radiation
3
Flow Cytometry
3
Cyclophosphamide
3
Biopsy
3
Bevacizumab
3
toripalimab
2
fludarabine phosphate
2
atezolizumab
2
aldesleukin
2
adavosertib
2
Zoledronic Acid
2
Topotecan
2
Nivolumab
2
Neoadjuvant Therapy
2
Microarray Analysis
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Interleukin-2
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Uterine Cervical Neoplasms
×
Blood Specimen Collection
×
Clear all
NCT02554565
2025-09-08
PAIR HPV
Institut Curie
Phase NA
Terminated
26 enrolled